TY - JOUR
AU - C. Lin
AU - H. Pham
AU - Y. Zhu
AU - S. E. Clingan
AU - L. A. Lin
AU - S. M. Murphy
AU - C. I. Campbell
AU - T. R. Sorrell
AU - Y. Liu
AU - L. J. Mooney
AU - Y. I. Hser
A1 - 
AD - Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA 90024, USA.; Department of Psychiatry, University of Michigan, 2800 Plymouth Road, Ann Arbor, MI 48109, USA; VA Center for Clinical Management Research, VA Ann Arbor Healthcare System, 2800 Plymouth Rd, Ann Arbor, MI 48109, USA.; Department of Population Health Sciences, Weill Cornell Medical College, New York, NY 10021, USA.; Center for Addiction and Mental Health Research, Division of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA 94612, USA; Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, 401 Parnassus Ave, San Francisco, CA 94143, USA.; University of Colorado College of Nursing, 13120 E. 19th Ave., Aurora, CO 80045, USA.; Center for Clinical Trials Network, National Institute on Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892, USA.; Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA 90024, USA; VA Greater Los Angeles Healthcare System, Los Angeles, CA 90073, USA.; Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA 90024, USA. Electronic address: yhser@ucla.edu.
AN - 36462230
BT - Drug Alcohol Depend
C5 - Opioids & Substance Use; HIT & Telehealth
DA - Jan 1
DO - 10.1016/j.drugalcdep.2022.109711
DP - NLM
ET - 20221123
JF - Drug Alcohol Depend
LA - eng
PY - 2023
SN - 0376-8716 (Print); 0376-8716
SP - 109711
ST - Telemedicine along the cascade of care for substance use disorders during the COVID-19 pandemic in the United States
T1 - Telemedicine along the cascade of care for substance use disorders during the COVID-19 pandemic in the United States
T2 - Drug Alcohol Depend
TI - Telemedicine along the cascade of care for substance use disorders during the COVID-19 pandemic in the United States
U1 - Opioids & Substance Use; HIT & Telehealth
U3 - 10.1016/j.drugalcdep.2022.109711
VL - 242
VO - 0376-8716 (Print); 0376-8716
Y1 - 2023
ER -